Lecozotan is a competitive, selective [[5-HT1A|5-HT<sub>1A</sub>]] [[receptor (biochemistry)|receptor]] [[antagonist]]<ref>{{cite journal|last=Schlechter|first=LE|date=June 10, 2005|title=Lecotozan (SRA-333): A selective serotonin1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and promotes procognitive effects|journal=Journal of Pharmacology and Experimental Therapeutics|url=http://jpet.aspetjournals.org/cgi/content/short/jpet.105.086363v1|pmid=15951399|doi=10.1124/jpet.105.086363|volume=314|pages=1274â€“89|last2=Smith|first2=DL|last3=Rosenzweig-Lipson|first3=S|last4=Sukoff|first4=SJ|last5=Dawson|first5=LA|last6=Marquis|first6=K|last7=Jones|first7=D|last8=Piesla|first8=M|last9=Andree|first9=T|last10=Nawoschik|first10=S|last11=Harder|first11=J. A.|last12=Womack|first12=M. D.|last13=Buccafusco|first13=J|last14=Terry|first14=A. V.|last15=Hoebel|first15=B|last16=Rada|first16=P|last17=Kelly|first17=M|last18=Abou-Gharbia|first18=M|last19=Barrett|first19=J. E.|last20=Childers|first20=W|issue=3|display-authors=8}}</ref>
